CMLFW
Cm Life Sciences Inc
A special purpose acquisition company — a "blank check" firm that raises money to buy a private business and take it public — CM Life Sciences was a trio of similar vehicles set up by the investment firms Casdin and Corvex. Each of the three merged with a different health-sciences company, becoming SemaLogic, GeneDx, and EQRx. The "CM" in the name strings together the initials of its two backers: Casdin and Meister.
WARRANTUnderlying: CMLFWCUSIP: 18978W117HealthcareUS1 holder
Redeemable warrant to purchase one share of Class A common stock at 1.50 — Acquired by Sema4 (now SMFR)
Total Value
$444.0K
Total Shares
162.8K
Net Share Change
+162.8K
Activity
1 buying
Investor
Value
Shares
Weight
Change
